FASN and cancer: CSN6 antagonizes cytosolic FBXW7β’s activity by enhancing FBXW7β autoubiquitination and degradation, thereby preventing FBXW7β/GSK3β-mediated FASN ubiquitination and degradation, lending support to why both CSN6 and FASN are positively correlated in cancer.